MichaelStencelDO, MS
Urology • Charleston, WVMinimally Invasive Surgery, Surgical Oncology
Urologic Oncologist
Dr. Stencel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 MacCorkle Ave SE
Suite 610
Charleston, WV 25304Phone+1 304-388-5280
Summary
- Dr. Michael Stencel is an attending urologic oncologist in Charleston, WV. He received his medical degree from Des Moines University College of Osteopathic Medicine, completed surgical internship and urology residency at West Virginia University and Charleston Area Medical Center. He further subspecialized in cancers of the urinary tract and male reproductive tract at the University of Pittsburgh. He specializes in minimally invasive surgery and surgical oncology. His research interests include urologic cancer outcomes and how health care policy reform can improve access to care.
Education & Training
UPMC Medical EducationFellowship, Minimally Invasive Urologic Surgery, 2021 - 2023
Charleston Area Medical Center/CAMC Institute for Academic MedicineChief Residency, Urology, 2020 - 2021- Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Urology, 2017 - 2020
West Virginia UniversityInternship, Surgery, 2016 - 2017
Des Moines University College of Osteopathic MedicineClass of 2016- Des Moines UniversityMS, Biomedical Science, 2016
Certifications & Licensure
WV State License 2016 - 2025- WV State License 2023 - 2025
PA State License 2021 - 2024
OH State License 2019 - 2022
Clinical Trials
- Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) Start of enrollment: 2020 May 19
- A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Start of enrollment: 2023 Dec 14
Publications & Presentations
PubMed
- 9 citationsLarge Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.Zeynep G Gul, Danielle R Sharbaugh, Cailey J Guercio, Daniel L Pelzman, Cameron A Jones
JAMA Network Open. 2023-01-03 - 4 citationsEndothelial regulation of calmodulin expression and eNOS-calmodulin interaction in vascular smooth muscle.Michael G Stencel, Mark VerMeer, Jennifer Giles, Quang-Kim Tran
Molecular and Cellular Biochemistry. 2022-05-01 - 3 citationsAn isolated case of an incidentally discovered neurofibroma of the urinary bladder.Bryce Baugh, Michael Stencel, Apexa Patel, Nathan Hale
Urology Case Reports. 2020-04-25
Authored Content
- The Complicated Cost of Prostate BiopsyApril 2022
Grant Support
- Qualitative evaluation of urologic cancer care delivery in an integrated healthcare delivery systemShadyside Foundation2022–2023
Professional Memberships
- Member
- American Urologic AssociationMember
- Society of Urologic OncologyMember
External Links
- WellPrepthttps://app.wellprept.com/michael-stencel-OZd4K
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
